(株)ヘリオスの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4593/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/10/23 | 日証協 | 329,100株 | +68.08% | 325,298株 | +9999.99% | 275,389株 | +52.08% | 156,505株 | +1838.14% |
| 2015/10/16 | 日証協 | 195,800株 | -0.41% | 2,800株 | -94.59% | 181,080株 | +2.43% | 8,075株 | -80.27% |
| 2015/10/09 | 日証協 | 196,600株 | +11.51% | 51,800株 | +88.36% | 176,787株 | +1.04% | 40,930株 | +207.28% |
| 2015/10/02 | 日証協 | 176,300株 | -23.68% | 27,500株 | +2650% | 174,975株 | -19.05% | 13,320株 | -3.48% |
| 2015/09/25 | 日証協 | 231,000株 | -5.09% | 1,000株 | -98.64% | 216,157株 | -2.79% | 13,800株 | -74.01% |
| 2015/09/18 | 日証協 | 243,400株 | -22.78% | 73,500株 | -68.79% | 222,357株 | -7.72% | 53,100株 | -57.96% |
| 2015/09/11 | 日証協 | 315,200株 | +251.39% | 235,500株 | +1083.42% | 240,957株 | +74.04% | 126,315株 | +426.2% |
| 2015/09/04 | 日証協 | 89,700株 | +10.6% | 19,900株 | +423.68% | 138,447株 | +10.99% | 24,005株 | +8.57% |
| 2015/08/28 | 日証協 | 81,100株 | +12.02% | 3,800株 | -84.23% | 124,742株 | +12.11% | 22,110株 | +48.22% |
| 2015/08/21 | 日証協 | 72,400株 | -38.75% | 24,100株 | -11.72% | 111,272株 | -19.23% | 14,917株 | -31.92% |
| 2015/08/14 | 日証協 | 118,200株 | +27.37% | 27,300株 | +184.38% | 137,760株 | +14.65% | 21,910株 | +543.47% |
| 2015/08/07 | 日証協 | 92,800株 | +1.09% | 9,600株 | -65.71% | 120,160株 | +1.02% | 3,405株 | -50.98% |
| 2015/07/31 | 日証協 | 91,800株 | +29.3% | 28,000株 | +3400% | 118,945株 | +1.02% | 6,946株 | -13.82% |
| 2015/07/24 | 日証協 | 71,000株 | +1.57% | 800株 | -82.61% | 117,749株 | +6.14% | 8,060株 | -36.59% |
| 2015/07/17 | 日証協 | 69,900株 | +6.23% | 4,600株 | 0% | 110,939株 | -89.11% | 12,710株 | -1.6% |
| 2015/07/10 | 日証協 | 65,800株 | +0.92% | 0株 | -100% | 1,018,982株 | +1.4% | 12,917株 | -51.09% |
| 2015/07/03 | 日証協 | 65,200株 | 0% | 600株 | -99.14% | 1,004,872株 | +0.91% | 26,410株 | +13.7% |
| 2015/06/26 | 日証協 | 65,200株 | -6.86% | 70,000株 | -44.09% | 995,762株 | +3.92% | 23,227株 | -84.34% |
| 2015/06/19 | 日証協 | 70,000株 | 0% | 125,200株 | 0% | 958,207株 | 0% | 148,335株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top